NGRN
geneOn this page
Also known as DSC92
Summary
NGRN (neugrin, neurite outgrowth associated, HGNC:18077) is a protein-coding gene on chromosome 15q26.1, encoding Neugrin (Q9NPE2). Plays an essential role in mitochondrial ribosome biogenesis. It is a selective cancer dependency (DepMap: 10.8% of cell lines).
Enables rRNA binding activity. Involved in mitochondrial ribosome assembly and positive regulation of mitochondrial translation. Located in several cellular components, including mitochondrion; mitotic spindle; and nuclear body.
Source: NCBI Gene 51335 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 51 total
- Cancer dependency (DepMap): dependent in 10.8% of screened cell lines
- MANE Select transcript:
NM_001033088
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18077 |
| Approved symbol | NGRN |
| Name | neugrin, neurite outgrowth associated |
| Location | 15q26.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DSC92 |
| Ensembl gene | ENSG00000182768 |
| Ensembl biotype | protein_coding |
| OMIM | 616718 |
| Entrez | 51335 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000331497, ENST00000379095, ENST00000411845, ENST00000885215, ENST00000885216, ENST00000939262, ENST00000961528
RefSeq mRNA: 1 — MANE Select: NM_001033088
NM_001033088
CCDS: CCDS32329
Canonical transcript exons
ENST00000379095 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001479750 | 90265672 | 90265876 |
| ENSE00001605534 | 90271188 | 90272211 |
| ENSE00003638144 | 90266288 | 90266398 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 99.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 74.8267 / max 943.8670, expressed in 1822 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 148429 | 60.4286 | 1822 |
| 148430 | 11.0742 | 1781 |
| 148432 | 1.4928 | 946 |
| 148433 | 0.5795 | 253 |
| 148434 | 0.5357 | 155 |
| 148437 | 0.5346 | 263 |
| 148431 | 0.1812 | 54 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| dorsolateral prefrontal cortex | UBERON:0009834 | 99.51 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 99.46 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 99.46 | gold quality |
| right frontal lobe | UBERON:0002810 | 99.45 | gold quality |
| prefrontal cortex | UBERON:0000451 | 99.44 | gold quality |
| frontal cortex | UBERON:0001870 | 99.43 | gold quality |
| cerebral cortex | UBERON:0000956 | 99.39 | gold quality |
| primary visual cortex | UBERON:0002436 | 99.39 | gold quality |
| cortical plate | UBERON:0005343 | 99.36 | gold quality |
| nucleus accumbens | UBERON:0001882 | 99.35 | gold quality |
| hypothalamus | UBERON:0001898 | 99.35 | gold quality |
| amygdala | UBERON:0001876 | 99.33 | gold quality |
| caudate nucleus | UBERON:0001873 | 99.32 | gold quality |
| putamen | UBERON:0001874 | 99.32 | gold quality |
| temporal lobe | UBERON:0001871 | 99.30 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 99.23 | gold quality |
| Ammon’s horn | UBERON:0001954 | 99.21 | gold quality |
| ganglionic eminence | UBERON:0004023 | 99.21 | gold quality |
| brain | UBERON:0000955 | 99.19 | gold quality |
| substantia nigra | UBERON:0002038 | 99.19 | gold quality |
| gastrocnemius | UBERON:0001388 | 99.12 | gold quality |
| muscle of leg | UBERON:0001383 | 99.00 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 98.92 | gold quality |
| ventricular zone | UBERON:0003053 | 98.91 | gold quality |
| cerebellar cortex | UBERON:0002129 | 98.83 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 98.83 | gold quality |
| cerebellum | UBERON:0002037 | 98.82 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 98.77 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.72 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 98.57 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-75688 | yes | 1251.11 |
| E-HCAD-10 | yes | 4.70 |
| E-HCAD-5 | no | 15.41 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting NGRN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
| HSA-MIR-222-3P | 99.86 | 71.35 | 1337 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-4255 | 99.72 | 67.70 | 1541 |
| HSA-MIR-12124 | 99.68 | 69.17 | 2700 |
| HSA-MIR-451B | 99.55 | 68.28 | 1380 |
| HSA-MIR-4999-3P | 99.11 | 65.55 | 424 |
| HSA-MIR-371A-5P | 99.08 | 66.51 | 1914 |
| HSA-MIR-140-3P | 99.04 | 67.69 | 1324 |
| HSA-MIR-6749-3P | 99.00 | 65.73 | 1443 |
| HSA-MIR-4257 | 97.86 | 68.05 | 1190 |
| HSA-MIR-493-3P | 97.50 | 66.44 | 731 |
| HSA-MIR-602 | 97.09 | 61.68 | 156 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 10.8% of screened cell lines.
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ngrn | ENSDARG00000061314 |
| mus_musculus | Ngrn | ENSMUSG00000047084 |
| rattus_norvegicus | Ngrn | ENSRNOG00000013553 |
Protein
Protein identifiers
Neugrin — Q9NPE2 (reviewed: Q9NPE2)
Alternative names: Mesenchymal stem cell protein DSC92, Neurite outgrowth-associated protein, Spinal cord-derived protein FI58G
All UniProt accessions (2): A0A087WWE0, Q9NPE2
UniProt curated annotations — full annotation on UniProt →
Function. Plays an essential role in mitochondrial ribosome biogenesis. As a component of a functional protein-RNA module, consisting of RCC1L, NGRN, RPUSD3, RPUSD4, TRUB2, FASTKD2 and 16S mitochondrial ribosomal RNA (16S mt-rRNA), controls 16S mt-rRNA abundance and is required for intra-mitochondrial translation of core subunits of the oxidative phosphorylation system.
Subunit / interactions. Forms a regulatory protein-RNA complex, consisting of RCC1L, NGRN, RPUSD3, RPUSD4, TRUB2, FASTKD2 and 16S mt-rRNA. Interacts with 16S mt-rRNA; this interaction is direct.
Subcellular location. Nucleus. Secreted. Mitochondrion membrane.
Tissue specificity. Expressed at high levels in heart, brain and skeletal muscle. In brain, mainly expressed in neurons rather than glial cells.
Induction. Highly up-regulated in neuroblastostoma cells by retinoic acid treatment inducing neurite outgrowth.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the neugrin family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NPE2-2 | 1 | yes |
| Q9NPE2-3 | 2 |
RefSeq proteins (1): NP_001028260* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010487 | NGRN/Rrg9 | Family |
Pfam: PF06413
UniProt features (15 total): glycosylation site 3, splice variant 2, sequence variant 2, sequence conflict 2, region of interest 2, signal peptide 1, chain 1, compositionally biased region 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NPE2-F1 | 68.87 | 0.35 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 41
Glycosylation sites (3): 158, 186, 268
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6793080 | rRNA modification in the mitochondrion |
| R-HSA-9937008 | Mitochondrial mRNA modification |
MSigDB gene sets: 152 (showing top):
GCM_MAP4K4, GOBP_RIBOSOME_BIOGENESIS, GCM_GSPT1, GCM_ZNF198, GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_RIBOSOME_ASSEMBLY, GOBP_NEUROGENESIS, LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_ORGANELLE_ASSEMBLY, GCM_SUFU, GCM_CALM1, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS
GO Biological Process (4): neuron differentiation (GO:0030182), mitochondrial ribosome assembly (GO:0061668), positive regulation of mitochondrial translation (GO:0070131), cell differentiation (GO:0030154)
GO Molecular Function (3): RNA binding (GO:0003723), rRNA binding (GO:0019843), protein binding (GO:0005515)
GO Cellular Component (10): extracellular region (GO:0005576), nucleus (GO:0005634), nucleoplasm (GO:0005654), mitochondrion (GO:0005739), mitochondrial matrix (GO:0005759), nuclear body (GO:0016604), mitochondrial membrane (GO:0031966), intercellular bridge (GO:0045171), mitotic spindle (GO:0072686), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| rRNA processing in the mitochondrion | 1 |
| Metabolism of RNA | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| intracellular membrane-bounded organelle | 2 |
| mitochondrion | 2 |
| cell differentiation | 1 |
| generation of neurons | 1 |
| ribosome assembly | 1 |
| mitochondrial translation | 1 |
| positive regulation of translation | 1 |
| regulation of mitochondrial translation | 1 |
| cellular developmental process | 1 |
| nucleic acid binding | 1 |
| RNA binding | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| intracellular organelle lumen | 1 |
| nucleoplasm | 1 |
| intracellular membraneless organelle | 1 |
| mitochondrial envelope | 1 |
| organelle membrane | 1 |
| spindle | 1 |
Protein interactions and networks
STRING
576 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NGRN | RPUSD4 | Q96CM3 | 877 |
| NGRN | FASTKD2 | Q9NYY8 | 861 |
| NGRN | RPUSD3 | Q6P087 | 846 |
| NGRN | TRUB2 | O95900 | 784 |
| NGRN | RCC1L | Q96I51 | 779 |
| NGRN | PTCD1 | O75127 | 761 |
| NGRN | GTPBP10 | A4D1E9 | 676 |
| NGRN | MRM3 | Q9HC36 | 676 |
| NGRN | NRGN | Q92686 | 575 |
| NGRN | MTERF3 | Q96E29 | 572 |
| NGRN | MTG2 | Q9H4K7 | 564 |
| NGRN | MALSU1 | Q96EH3 | 555 |
| NGRN | DDX28 | Q9NUL7 | 514 |
| NGRN | MTERF4 | Q7Z6M4 | 512 |
| NGRN | NSUN4 | Q96CB9 | 476 |
IntAct
126 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NOP53 | RRP8 | psi-mi:“MI:0914”(association) | 0.640 |
| LIN28A | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| GTF2H5 | NGRN | psi-mi:“MI:0915”(physical association) | 0.560 |
| YOD1 | NGRN | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF324B | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| RBM3 | PRMT5 | psi-mi:“MI:0914”(association) | 0.530 |
| CIRBP | PRMT5 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL7 | ZBTB24 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL42 | GATC | psi-mi:“MI:0914”(association) | 0.530 |
| RPL6 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| RBMX | PTCD1 | psi-mi:“MI:0914”(association) | 0.530 |
| DDX28 | PTCD1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| ZC3HAV1 | KHNYN | psi-mi:“MI:0914”(association) | 0.530 |
| HNRNPA1 | PTCD1 | psi-mi:“MI:0914”(association) | 0.530 |
| IGF2BP3 | PTCD1 | psi-mi:“MI:0914”(association) | 0.530 |
| NGRN | RPL7 | psi-mi:“MI:0914”(association) | 0.530 |
| RBM3 | AARS2 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL13 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| SRSF3 | CASC3 | psi-mi:“MI:0914”(association) | 0.530 |
| NGRN | DCTD | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (300): NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), NGRN (Affinity Capture-MS), WBSCR16 (Affinity Capture-MS), RPUSD3 (Affinity Capture-MS)
ESM2 similar proteins: A0JPN4, A2AKB4, A6NDY0, A6NP61, A7E321, B0BNE4, B1ASB6, O54824, O88286, O95931, P60924, Q14005, Q14154, Q1XFL1, Q3T1H2, Q3TYG6, Q3ZBR0, Q49AM3, Q4R2Z8, Q4R747, Q4VXA5, Q5R7E7, Q5SU73, Q5SXM2, Q5SYB0, Q5XFR0, Q6NVP7, Q6P1D7, Q6ZUX3, Q7Z572, Q7ZXB8, Q80VM8, Q8BG34, Q8BIY3, Q8BLK9, Q8BP86, Q8IY92, Q8K124, Q93075, Q96FV0
Diamond homologs: A1C6R8, A1DHD8, A2QCR5, A3LTV8, A5DKF1, A5DZ02, A6ZRM7, A7EJ50, A7TIC4, B0XSW5, B2W722, B3LP57, B5VQJ9, B6HDT2, B6QGW6, B8MLF7, B8NHF2, C0SC25, C1GIF2, C4JXN2, C4R331, C5DD31, C5DTR1, C5FNG9, C5GEF3, C5JS82, C5PBQ8, C7GPE4, C8ZG19, D1ZQ10, D4AKN8, D4DHC4, E3L408, E3REX1, E4UQC3, O14211, P0C8Z6, P40156, Q0CYR5, Q0TY47
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 112 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial translation initiation | 15 | 27.2× | 6e-16 |
| Mitochondrial translation elongation | 15 | 27.2× | 6e-16 |
| Mitochondrial ribosome-associated quality control | 15 | 26.3× | 6e-16 |
| Mitochondrial translation | 12 | 23.6× | 4e-12 |
| Mitochondrial translation termination | 15 | 23.5× | 3e-15 |
| Translation | 14 | 12.4× | 2e-10 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | 5 | 10.9× | 2e-03 |
| Processing of Capped Intron-Containing Pre-mRNA | 9 | 10.6× | 6e-06 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| negative regulation of mRNA splicing, via spliceosome | 5 | 36.8× | 3e-05 |
| mitochondrial translation | 17 | 28.4× | 8e-18 |
| positive regulation of mRNA splicing, via spliceosome | 5 | 26.1× | 1e-04 |
| regulation of alternative mRNA splicing, via spliceosome | 6 | 14.1× | 3e-04 |
| mRNA transport | 5 | 12.7× | 3e-03 |
| translation | 12 | 11.9× | 9e-08 |
| RNA processing | 5 | 10.5× | 5e-03 |
| mRNA splicing, via spliceosome | 9 | 7.9× | 2e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
51 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 3 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
745 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:90265866:G:GT | donor_gain | 1.0000 |
| 15:90266394:A:G | donor_gain | 0.9900 |
| 15:90265856:G:GT | donor_gain | 0.9800 |
| 15:90265874:G:GT | donor_gain | 0.9800 |
| 15:90265874:GAGGT:G | donor_loss | 0.9800 |
| 15:90265876:GGTAC:G | donor_loss | 0.9800 |
| 15:90265877:G:T | donor_loss | 0.9800 |
| 15:90266286:A:AG | acceptor_gain | 0.9800 |
| 15:90266287:G:GG | acceptor_gain | 0.9800 |
| 15:90265870:TGGAG:T | donor_gain | 0.9700 |
| 15:90265874:GAG:G | donor_gain | 0.9700 |
| 15:90266287:GC:G | acceptor_gain | 0.9700 |
| 15:90266394:ATACG:A | donor_loss | 0.9700 |
| 15:90266396:ACG:A | donor_loss | 0.9700 |
| 15:90266397:CGGTG:C | donor_loss | 0.9700 |
| 15:90266398:GGTGA:G | donor_loss | 0.9700 |
| 15:90266399:G:GG | donor_gain | 0.9700 |
| 15:90266399:GTGAG:G | donor_loss | 0.9700 |
| 15:90266400:TGAGA:T | donor_loss | 0.9700 |
| 15:90266401:GAGAC:G | donor_loss | 0.9700 |
| 15:90266410:GA:G | donor_gain | 0.9700 |
| 15:90266692:GCA:G | donor_gain | 0.9700 |
| 15:90265852:A:T | donor_gain | 0.9600 |
| 15:90266287:GCA:G | acceptor_gain | 0.9600 |
| 15:90266287:GCACC:G | acceptor_gain | 0.9600 |
| 15:90266403:G:C | donor_loss | 0.9600 |
| 15:90266693:C:T | donor_gain | 0.9600 |
| 15:90267618:GGC:G | donor_gain | 0.9600 |
| 15:90267619:GCG:G | donor_gain | 0.9600 |
| 15:90265871:GGAGA:G | donor_gain | 0.9500 |
AlphaMissense
1885 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:90271243:T:C | F111L | 0.994 |
| 15:90271245:T:A | F111L | 0.994 |
| 15:90271245:T:G | F111L | 0.994 |
| 15:90271232:T:C | L107S | 0.990 |
| 15:90271235:C:A | A108D | 0.984 |
| 15:90271193:T:C | L94S | 0.981 |
| 15:90266395:T:C | I91T | 0.980 |
| 15:90271216:T:A | W102R | 0.979 |
| 15:90271216:T:C | W102R | 0.979 |
| 15:90271288:T:C | F126L | 0.978 |
| 15:90271290:T:A | F126L | 0.978 |
| 15:90271290:T:G | F126L | 0.978 |
| 15:90271274:T:A | V121D | 0.972 |
| 15:90271234:G:C | A108P | 0.971 |
| 15:90266398:G:C | R92P | 0.967 |
| 15:90271244:T:C | F111S | 0.965 |
| 15:90271265:T:A | I118N | 0.965 |
| 15:90271218:G:C | W102C | 0.964 |
| 15:90271218:G:T | W102C | 0.964 |
| 15:90271750:T:C | F280L | 0.963 |
| 15:90271752:C:A | F280L | 0.963 |
| 15:90271752:C:G | F280L | 0.963 |
| 15:90271272:A:C | R120S | 0.962 |
| 15:90271272:A:T | R120S | 0.962 |
| 15:90266366:G:C | R81S | 0.958 |
| 15:90266366:G:T | R81S | 0.958 |
| 15:90266382:G:C | A87P | 0.957 |
| 15:90271250:T:A | V113D | 0.957 |
| 15:90271243:T:A | F111I | 0.954 |
| 15:90266395:T:A | I91K | 0.948 |
dbSNP variants (sampled 300 via entrez): RS1000280670 (15:90267815 A>G), RS1000284543 (15:90268000 CGTTTGTTT>C,CGTTT,CGTTTGTTTGTTT), RS1000696502 (15:90268020 G>A), RS1003068902 (15:90269924 A>G), RS1003409078 (15:90271312 C>A), RS1003452079 (15:90269672 C>A,G,T), RS1003684193 (15:90263726 C>A,T), RS1004854797 (15:90265293 A>G,T), RS1005473924 (15:90267116 C>G), RS1006041786 (15:90271905 T>C), RS1006365562 (15:90265950 G>A,T), RS1006469759 (15:90265649 G>A,T), RS1006948112 (15:90270398 C>T), RS1007260590 (15:90267779 A>G), RS1007486289 (15:90264497 C>G,T)
Disease associations
OMIM: gene MIM:616718 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009597_254 | Multiple sclerosis | 1.000000e-12 |
| GCST012481_11 | Cerebral amyloid angiopathy in Alzheimer’s disease | 3.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, decreases methylation | 3 |
| Cyclosporine | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol F | affects cotreatment, decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects expression | 1 |
| potassium chromate(VI) | increases expression, affects cotreatment | 1 |
| epigallocatechin gallate | increases expression, affects cotreatment | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| K 7174 | increases expression | 1 |
| abrine | increases expression | 1 |
| picoxystrobin | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants, Occupational | affects expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Dexamethasone | decreases expression, affects cotreatment | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Lead | affects expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Rotenone | decreases expression | 1 |
| Sarin | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Zinc | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cerebral amyloid angiopathy